Company News
Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer
Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer
He will be responsible for the clinical strategy and development of Cristal Therapeutics’ nanomedicines
Valeant Pharmaceuticals names Joseph Papa as Chairman and Chief Executive
Valeant Pharmaceuticals names Joseph Papa as Chairman and Chief Executive
He brings more than 30 years of leadership and operations experience in healthcare to the firm
Paul Doody heads global marketing at Domino Printing Sciences
Paul Doody heads global marketing at Domino Printing Sciences
He brings a wealth of experience to the Cambridge, UK-based coding and marking specialist
XenoGesis strengthens DMPK team with appointment of Peter White
XenoGesis strengthens DMPK team with appointment of Peter White
He specialises in mass spectrometry and bioanalysis
Scottish CMO Symbiosis strengthens US presence
Scottish CMO Symbiosis strengthens US presence
Appoints Dr Thomas Scullion as US Business Development Manager
David Lescuyer joins SkyePharma as Executive Vice President, Oral Business
David Lescuyer joins SkyePharma as Executive Vice President, Oral Business
He will be responsible for Skyepharma’s Oral Business including, after 30 June, the manufacturing operations in Saint-Quentin Fallavier, France
Kymab hires leaders in immuno-oncology, infectious disease and blood disorders
Kymab hires leaders in immuno-oncology, infectious disease and blood disorders
Appointments bring internationally recognised expertise to strengthen Kymab’s key therapeutic areas
Adapt Pharma names Mike Kelly as President of US operations
Adapt Pharma names Mike Kelly as President of US operations
He contributes more than 25 years of pharmaceutical expertise to Adapt executive team
Dr Richard Butt to become CEO of Apollo Therapeutics
Dr Richard Butt to become CEO of Apollo Therapeutics
He will join the investment fund from Pfizer Neusentis
Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult
Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult
Quinn has been Chief Medical Officer of the organisation for the past six months
Nigel Bond joins Brother executive management team
Nigel Bond joins Brother executive management team
Follows acquisition of Domino Printing Sciences by Japanese firm
Merck appoints Maya Martinez-Davis as Global Head of Oncology
Merck appoints Maya Martinez-Davis as Global Head of Oncology
Her role will include defining global oncology strategies and delivering therapeutic launches
President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest
President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest
Susanne Resatz will help GACC Midwest further promote and expand bilateral trade and investment between the Midwest and Germany
Probiodrug appoints Mark Booth as Chief Business Officer
Probiodrug appoints Mark Booth as Chief Business Officer
The move expands the German firm's Management Board
Novavax announces management promotion
Novavax announces management promotion
Iksung Cho has been named as Vice President, Biostatistics
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
He will lead all global R&D across the oncology therapeutic area
New Technical Officer for ReFaC
New Technical Officer for ReFaC
Kim Shillington joins the UK firm
ESMO appoints first Chief Medical Officer
ESMO appoints first Chief Medical Officer
New position reflects ESMO’s rapid growth and follows extensive six-month selection process
Paragon Bioservices appoints Bill Thomas as Chief Technology Officer
Paragon Bioservices appoints Bill Thomas as Chief Technology Officer
Vaccines industry veteran was most recently with MassBiologics
Cypralis hires Dr Michael Peel as Chief Scientific Officer
Cypralis hires Dr Michael Peel as Chief Scientific Officer
He joins the UK life sciences firm from Scynexis, where he was Director of Discovery
Valeant Pharmaceuticals makes management change
Valeant Pharmaceuticals makes management change
In its US Dermatology and Gastrointestinal businesses
Rigel names Anne-Marie Duliege as Chief Medical Officer
Rigel names Anne-Marie Duliege as Chief Medical Officer
Elliott Grossbard retires but will continue advising on NDA filing for fostamatinib
New Chief Medical Officer at Arvinas
New Chief Medical Officer at Arvinas
Angela Shen brings extensive experience in clinical development, medical affairs and business development to the firm
HUYA Bioscience appoints John Ratliff as President and CEO
HUYA Bioscience appoints John Ratliff as President and CEO
He was previously President/COO of Quintiles' Global Services organisation